Free Trial

Oragenics (OGEN) Insider Trading & Ownership

Oragenics logo
$0.27 -0.02 (-6.04%)
(As of 05:38 PM ET)

Oragenics (NYSE:OGEN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$12,495.00
Get OGEN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oragenics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OGEN Insider Buying and Selling by Quarter

Oragenics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/30/2023Fred TellingDirectorSell3,500$3.57$12,495.00  
(Data available from 1/1/2013 forward)

OGEN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Oragenics includes Fred Telling, Michael O'keefe Sullivan, and Robert C Koski. Learn more on insiders at OGEN.

10.10% of Oragenics stock is owned by insiders. Learn more on OGEN's insider holdings.

The following insiders have sold OGEN shares in the last 24 months: Fred Telling ($12,495.00), and Robert C Koski ($47,752.20).

Insiders have sold a total of 7,646 Oragenics shares in the last 24 months for a total of $60,247.20 sold.

Oragenics Key Executives

  • Mr. Charles L. Pope CPA (Age 72)
    Executive Chairman
    Compensation: $112.5k
  • Mr. Joseph Michael Redmond (Age 63)
    President & Interim Principal Executive Officer
  • Ms. Janet Huffman (Age 52)
    CFO, Secretary & Treasurer
    Compensation: $314.9k
  • Dr. James P. Kelly M.A.
    M.D., Chief Medical Officer & Member of Scientific Advisor


This page (NYSE:OGEN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners